Dissecting bulk transcriptomes of diffuse large B cell lymphoma
- PMID: 34597590
- DOI: 10.1016/j.ccell.2021.09.006
Dissecting bulk transcriptomes of diffuse large B cell lymphoma
Abstract
Diffuse large B cell lymphoma (DLBCL) is a markedly phenotypically heterogenous disease, frequently assessed using bulk genomic techniques that blur the intrinsic heterogeneity of each tumor. In this issue of Cancer Cell, Steen et al. have utilized a computational framework called EcoTyper to skillfully dissect bulk transcriptomic tumor profiles into different cell type components in an unsupervised manner.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests A.M. has consulted for Epizyme, Constellation, Daiichi Sankyo, AstraZeneca, BMS, Janssen, and ExoTherapeutics. A.M. has research funding from Epizyme, Janssen, Daiichi Sankyo, and AstraZeneca. A.M. is on the advisory board of KDAC. O.E. is supported by Janssen, Johnson and Johnson, Volastra Therapeutics, AstraZeneca, and Eli Lilly research grants. O.E. is scientific advisor and equity holder in Freenome, Owkin, Volastra Therapeutics, and One Three Biotech.
Comment on
-
Atlas of clinically distinct cell states and ecosystems across human solid tumors.Cell. 2021 Oct 14;184(21):5482-5496.e28. doi: 10.1016/j.cell.2021.09.014. Epub 2021 Sep 30. Cell. 2021. PMID: 34597583 Free PMC article.
-
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.Cancer Cell. 2021 Oct 11;39(10):1422-1437.e10. doi: 10.1016/j.ccell.2021.08.011. Epub 2021 Sep 30. Cancer Cell. 2021. PMID: 34597589 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
